Haematological disorders in pregnancy

Author(s):  
Amanda Ali ◽  
Hassan Shehata

During the last four decades, there have been major advances in the understanding and management of the haematological disorders associated with pregnancy. This chapter aims to help update the management and knowledge of some of these conditions. The section on anaemia in pregnancy addresses its prevention, diagnosis, and management. Sickle cell disease is discussed, with its associated complications and the role of preconception and antenatal care in the appropriate set-up. The section on thalassemia highlights the advances in antenatal screening and the management of the different types in pregnancy. A concise updated review on antiphospholipid syndrome in pregnancy is included, addressing its diagnosis and management. Early pregnancy loss is the most common pregnancy complication and its occurrence in association with a thrombophilia is discussed in detail. Women with inherited bleeding disorders and disseminated intravascular coagulopathy may face several haemostatic challenges during pregnancy and childbirth. Pregnancy in these women requires specialized and individualized care. This section covers the management of maternal and fetal complications as well as prenatal diagnosis including new advances for haemophilia carriers. The section on thrombocytopenia outlines the management of low platelets in pregnancy, and the association with severe pre-eclampsia, eclampsia, and HELLP syndrome. There is a section devoted to management of haematological malignancies in pregnancy, which is complex and requires a multidisciplinary approach. An attempt has been made to cover as many subjects in a way that will be of interest and value to both obstetricians and haematologists involved in the care of pregnant women.

Author(s):  
S. Eli ◽  
G. P. Tee Popnen ◽  
D. G. B. Kalio ◽  
N. C. T. Briggs ◽  
K. E. Okagua

Background: Anaemia in pregnancy is an indirect cause of maternal mortality. Myriad of factors predispose pregnant women to anaemia in pregnancy in the developing countries of the world of which poverty, illiteracy and ignorance are central. The prevalence of anaemia in the developing countries of the world is between 32% and 62.2%. Objective: To determine the prevalence of anaemia amongst antenatal clinic attendees in Ogoni, South-South Nigeria and offer preventive measures. Material and Methods: This was a retrospective four months cross-sectional study of antenatal clinic attendees at booking in three (3) primary health care facilities and general hospitals Bori and Tera, in Ogoni, South-South Nigeria. Three hundred and eighty (380) pregnant women’s biodata including their packed cell volume were collected. These pieces of information were computed using a structured proforma. The data were coded and analysed using statistical package for social sciences (SPSS) software version 25. Results: The mean age of the study antenatal clinic attendees was 28 years. The mean gestational age at booking was 25weeks. The range for the packed cell volume was 25% to 36% and the mean packed cell volume at booking was 30%. Three hundred and eighteen (318) (84.0%) had anaemia (with packed cell volume less than 33%). Majority of patients 249 (65.6%) had mild anaemia There was none with severe anaemia. Majority of patients had secondary level of education represented by 275 (72.3%). Conclusion: The prevalence of anaemia amongst antenatal clinic attendees at Ogoni was 84.0%. The role of pre-pregnancy care amongst women desirous of pregnancy, familly planning and the role of education cannot be over emphasized in the prevention of anaemia in pregnancy.


2010 ◽  
Vol 3 (3) ◽  
pp. 211-214 ◽  
Author(s):  
OM Akanbi ◽  
AB Odaibo ◽  
R Olatoregun ◽  
AB Ademowo

2016 ◽  
Vol 146 (10) ◽  
pp. 429-435
Author(s):  
Xavier Urquizu i Brichs ◽  
Mónica Rodriguez Carballeira ◽  
Antonio García Fernández ◽  
Emilio Perez Picañol

2006 ◽  
Vol 22 (2) ◽  
Author(s):  
Paul A Feyi-Waboso ◽  
Aluka Chris ◽  
Godfrey C Nwaogu ◽  
Eric I Archibong ◽  
Eke C Ejikem

2020 ◽  
Vol 15 (9) ◽  
pp. 1371-1380 ◽  
Author(s):  
Kate Wiles ◽  
Lucy C. Chappell ◽  
Liz Lightstone ◽  
Kate Bramham

It is estimated that women with CKD are ten times more likely to develop preeclampsia than women without CKD, with preeclampsia affecting up to 40% of pregnancies in women with CKD. However, the shared phenotype of hypertension, proteinuria, and impaired excretory kidney function complicates the diagnosis of superimposed preeclampsia in women with CKD who have hypertension and/or proteinuria that predates pregnancy. This article outlines the diagnoses of preeclampsia and superimposed preeclampsia. It discusses the pathogenesis of preeclampsia, including abnormal placentation and angiogenic dysfunction. The clinical use of angiogenic markers as diagnostic adjuncts for women with suspected preeclampsia is described, and the limited data on the use of these markers in women with CKD are presented. The role of kidney biopsy in pregnancy is examined. The management of preeclampsia is outlined, including important advances and controversies in aspirin prophylaxis, BP treatment targets, and the timing of delivery.


1994 ◽  
Vol 10 (2) ◽  
pp. 273-281 ◽  
Author(s):  
Inger Stauning

AbstractNew medical technologies are often developed and diffused in health care without societal assessments or setting of priorities. This article discusses the driving forces behind the development of new technologies and asks how women as users and providers of health services can gain influence on the process. Technologies used in pregnancy and childbirth are discussed to reveal different interests in their development and use and to discuss the role of industry in the development of new medical technologies in general.


2021 ◽  
Vol 10 (13) ◽  
pp. 2956
Author(s):  
Dalal S. Ali ◽  
Karel Dandurand ◽  
Aliya A. Khan

Background: Parathyroid disease is uncommon in pregnancy. During pregnancy, multiple changes occur in the calcium regulating hormones which may make the diagnosis of primary hyperparathyroidism more challenging. Close monitoring of serum calcium during pregnancy is necessary in order to optimize maternal and fetal outcomes. In this review, we will describe the diagnosis and management of primary hyperparathyroidism during pregnancy. Methods: We searched MEDLINE, CINAHL, EMBASE and Google scholar bases from 1 January 1990 to 31 December 2020. Case reports, case series, book chapters and clinical guidelines were included in this review. Conclusions: Medical management options for primary hyperparathyroidism during pregnancy are severely limited due to inadequate safety data with the various potential therapies available, and surgery is advised during the 2nd trimester of pregnancy in the presence of severe hypercalcemia (calcium adjusted for albumin greater than 3.0 mmol/L (12.0 mg/dL)). Hypercalcemia should be avoided during pregnancy in order to minimize maternal and fetal complications.


Sign in / Sign up

Export Citation Format

Share Document